European Prurigo Project (EPP) of the EADV Task Force Pruritus

European Prurigo Project (EPP) of the EADV Task Force Pruritus - EPP

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00012876

Enrollment

500

Registered

2017-08-09

Start date

2017-08-23

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L28.1 L28.2

Interventions

Group 1: Assessment of aspects of chronic prurigo disease including, co-medication, concomitant diseases, symptoms, underlying causes, impairment of quality of life, effective treatment options, thera

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with chronic prurigo (L28.1, L28.2)

Exclusion criteria

Exclusion criteria: Patients younger than 18 years. Patients who cannot complete the questionnaires due to physical or psychiatric diseases.

Design outcomes

Primary

Measure	Time frame
Patient-reported outcomes: - Demographics: age, sex, height, weight, skin type, education, employment, age when chronic prurigo started - Medical history: current comorbidities, atopic predisposition, current medication - Clinical profile: current itch intensity, current skin lesions, paresthesias, quality of life, associated burdensome factors, emotional burden, underlying diseases - Health care situation and economy: current therapy for chronic prurigo, performed therapies in the past 6 months, satisfaction with the therapy in the past 6 months, estimated out of pocket costs in the past 6 months, therapy needs. - Feasibility assessment of the electronic questionnaire Physician-reported outcomes: - general information: sex, age at first visit at the center, current age, first and last visit at the center, number of visits, number of inpatient stays, number of inpatient stay days. - etiology of the chronic prurigo - comorbidities - co-medication - Past treatments and current treatments These data will be assessed by means of an electronic survey.	—

Measure

Time frame

Patient-reported outcomes: - Demographics: age, sex, height, weight, skin type, education, employment, age when chronic prurigo started - Medical history: current comorbidities, atopic predisposition, current medication - Clinical profile: current itch intensity, current skin lesions, paresthesias, quality of life, associated burdensome factors, emotional burden, underlying diseases - Health care situation and economy: current therapy for chronic prurigo, performed therapies in the past 6 months, satisfaction with the therapy in the past 6 months, estimated out of pocket costs in the past 6 months, therapy needs. - Feasibility assessment of the electronic questionnaire Physician-reported outcomes: - general information: sex, age at first visit at the center, current age, first and last visit at the center, number of visits, number of inpatient stays, number of inpatient stay days. - etiology of the chronic prurigo - comorbidities - co-medication - Past treatments and current treatments These data will be assessed by means of an electronic survey.

—

Countries

Austria, Belgium, France, Germany, India, Italy, Norway, Poland, Portugal, Russia, Spain, Sweden, Switzerland, Turkey

Contacts

Public ContactManuel Pereira

Klinik für Hautkrankheiten und Kompetenzzentrum chronischer Pruritus (KCP), Universitätsklinikum Münster

juckreizambulanz@ukmuenster.de00492518356501

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026